Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.010
-0.130 (-6.07%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
-0.010 (-0.50%)
After-hours: Dec 5, 2025, 7:57 PM EST
Pulmonx Revenue
Pulmonx had revenue of $21.50M in the quarter ending September 30, 2025, with 5.47% growth. This brings the company's revenue in the last twelve months to $91.66M, up 15.59% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.
Revenue (ttm)
$91.66M
Revenue Growth
+15.59%
P/S Ratio
0.88
Revenue / Employee
$314,997
Employees
291
Market Cap
82.91M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LUNG News
- 3 days ago - Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Pulmonx Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025 - GlobeNewsWire
- 7 weeks ago - Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025 - GlobeNewsWire
- 3 months ago - Pulmonx to Participate in September Investor Conferences - GlobeNewsWire
- 4 months ago - Pulmonx (LUNG) Q2 Revenue Rises 15% - The Motley Fool
- 4 months ago - Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript - Seeking Alpha